Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Price Performance

Shares of NASDAQ RKDA opened at $3.32 on Friday. The business’s 50-day moving average price is $4.53 and its two-hundred day moving average price is $4.10. Arcadia Biosciences has a one year low of $1.85 and a one year high of $10.31. The company has a market capitalization of $4.54 million, a P/E ratio of -0.78 and a beta of 0.86.

Institutional Trading of Arcadia Biosciences

A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences as of its most recent filing with the SEC. Institutional investors own 17.73% of the company’s stock.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.